DAX-0,04 % EUR/USD+0,23 % Gold0,00 % Öl (Brent)+0,99 %

Ocular TherapeutixAktie

WKN: A1180P | Symbol: 0OT
5,060
 
EUR
09:00:37 Frankfurt
-0,20 %
-0,010 EUR
Geldkurs 14:21:32
5,070 EUR
600 Stk.
Briefkurs 15:22:29
5,260 EUR
600 Stk.
Mehr Daten anzeigen
NewsFlashAnzeige
Eilmeldung! Countdown läuft ab - Jetzt investieren!

Ocular Therapeutix Chart

Neuigkeiten zur Ocular Therapeutix Inc Aktie

ZeitTitel
09.04.18

Ocular Therapeutix™ to Present Data at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium
22.03.18

Ocular Therapeutix™ To Present at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo, Monaco on April 8-10, 2018
08.03.18

Ocular Therapeutix™ Reports Fourth Quarter and Year End 2017 Financial Results and Business Update
28.02.18

Ocular Therapeutix™ to Present at the Cowen and Company 38th Annual Health Care Conference
27.02.18

Ocular Therapeutix™ To Report Fourth Quarter 2017 Financial Results
08.02.18

Ocular Therapeutix™ to Participate in the 2018 Glaucoma 360 Meeting in San Francisco
29.01.18

Ocular TherapeutixTM Announces Closing of Public Offering of Common Stock
25.01.18

Ocular TherapeutixTM Announces Pricing of Public Offering of Common Stock
24.01.18

Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock
22.12.17

Ocular Therapeutix™ Provides Legal Update
05.12.17

Ocular Therapeutix™ to Participate in the Guggenheim Securities 5th Annual Boston Healthcare Conference
07.11.17

Ocular Therapeutix™ Reports Third Quarter 2017 Financial Results and Provides Corporate Update
31.10.17

Ocular Therapeutix™ to Report Third Quarter 2017 Financial Results
26.09.17

Robbins Arroyo LLP Is Investigating the Officers and Directors of Ocular Therapeutix, Inc. (OCUL) on Behalf of Shareholders
25.09.17

Ocular Therapeutix™ Appoints Donald Notman as Chief Financial Officer

Die neusten Nachrichten zu Ocular Therapeutix

ZeitTitel
09.04.18
Ocular Therapeutix™ to Present Data at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium
22.03.18
Ocular Therapeutix™ To Present at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo, Monaco on April 8-10, 2018
08.03.18
Ocular Therapeutix™ Reports Fourth Quarter and Year End 2017 Financial Results and Business Update
28.02.18
Ocular Therapeutix™ to Present at the Cowen and Company 38th Annual Health Care Conference
27.02.18
Ocular Therapeutix™ To Report Fourth Quarter 2017 Financial Results
mehr Ocular Therapeutix Nachrichten »

Indexzugehörigkeit von Ocular Therapeutix

WertpapierPerf. %
Nasdaq
-0,05
NASDAQ Global Market Composite Index
-0,36
Russell 2000 (calculated by Bridge Data Services)
-0,03
NASDAQ Health Care Index
+0,19
Nasdaq US Small Cap Growth Index
-0,30
Nasdaq DM Ex Korea Small Cap EUR Index Net Total Return
-0,06
Nasdaq DM Ex Korea Small Cap Index Net Total Return
-0,41
Nasdaq DM Ex Korea Small Cap JPY Index Net Total Return
-0,28
Nasdaq DM Ex Korea Small Cap AUD Index
+0,01
NASDAQ OMX NASDAQ Composite Total Return Index
-0,05
Alle zugehörigen Indizes »

Aktienkurs Ocular Therapeutix A1180P

BörsenplatzFrankfurt
Letzter Kurs5,060EUR
Performance-0,20 %
Kurszeit09:00:37
Eröffnung5,060EUR
Tageshoch5,060EUR
Tagestief5,060EUR
Vortageskurs5,070EUR
52-Wochen Hoch10,176EUR
52-Wochen Tief3,074EUR
Anzahl Trades1
Performance 1 Monat-6,63 %
Performance 1 Jahr-39,49 %

Stammdaten zu Ocular Therapeutix

NameOcular Therapeutix Inc
KurznameOcular Therap
NamenszusatzRegistered Shs
KategorieAktien
AktientypStammaktien
WKNA1180P
Symbol0OT
BranchePharmaindustrie
LandUSA USA
ReferenzwährungUSD
Aktienanzahl37,28 Mio.
Marktkapitalisierung188,63 Mio.EUR

Performance Ocular Therapeutix Aktie

ZeitKursPerf.
1 Tag5,060EUR
-0,20 %
1 Woche5,070EUR
0,00 %
1 Monat5,430EUR
-6,63 %
3 Monate4,180EUR
+21,29 %
6 Monate5,013EUR
+1,14 %
Lfd. Jahr3,676EUR
+37,92 %
1 Jahr8,379EUR
-39,49 %
3 Jahre24,017EUR
-78,89 %
mehr Performancedaten »
Adresse und Kontaktdaten
NameOcular Therapeutix Inc
StadtBedford, MA
LandUSA USA
Webseitewww.ocutx.com
Aktionäre interessieren sich auch für:
#WertpapierPerf. %
1.
Novavax
+4,25
2.
Biofrontera
+0,71
3.
Bioline RX (Spons. ADR)
-0,52
4.
Genocea Biosciences
+1,60
5.
Applied Genetic Technologies
-3,07
6.
HealthSpace Data Systems
-4,26
7.
Orexigen Therapeutics
-14,39
8.
Leafbuyer Technologies
-1,71
9.
Cannabis Wheaton Income
+1,08
10.
Rocket Pharmaceuticals
+1,12

Emissionsinformationen

Emissionspreis13,000EUR
Emissionsvolumen5.000.000Stück
ZeichnungsgebührNein
IPO Anmeldetag20.06.2014
IPO25.07.2014
PlatzierungÖffentlich

Handelsinformationen

Haupthandel09:00 - 20:00 Uhr
Liquidister HandelsplatzNasdaq